FSD Pharma Inc. (NASDAQ:HUGE) Sees Large Decrease in Short Interest

FSD Pharma Inc. (NASDAQ:HUGEGet Rating) saw a large drop in short interest in the month of April. As of April 15th, there was short interest totalling 367,400 shares, a drop of 27.8% from the March 31st total of 508,700 shares. Based on an average daily trading volume, of 177,000 shares, the short-interest ratio is currently 2.1 days. Approximately 2.1% of the company’s shares are sold short.

Shares of NASDAQ HUGE remained flat at $$1.01 during midday trading on Monday. The stock had a trading volume of 696 shares, compared to its average volume of 162,670. The business’s fifty day moving average is $0.95. FSD Pharma has a one year low of $0.80 and a one year high of $2.25.

FSD Pharma Company Profile (Get Rating)

FSD Pharma Inc, through its subsidiaries, operates as a pharmaceutical research and development company. Its lead candidate includes FSD-201 that is in the Phase II clinical trial to treat COVID-19 disease. The company also focuses on Lucid-PSYCH, a psychoactive molecule identified for the potential treatment of neuropsychiatric disorders, such as depressive disorder; and Lucid-MS, a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models.

Read More

Receive News & Ratings for FSD Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for FSD Pharma and related companies with MarketBeat.com's FREE daily email newsletter.